NCT07114939
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
- Locations
-
- University of Pennsylvania, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,967 public trials
1,828 recruiting studies
Lymphatic Diseases trial results
NCT03666000
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +27 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- City of Hope Duarte, California, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Winship Cancer Institute Emory University Atlanta, Georgia, United States
NCT05180097
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- Concord Repatriation General Hospital Concord, New South Wales, Australia
- Shoalhaven Cancer Care Centre Nowra, New South Wales, Australia
- Wollongong Hospital Wollongong, New South Wales, Australia
- Royal Adelaide Hospital Adelaide, South Australia, Australia
NCT05633615
- Conditions
- Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT04390737
- Conditions
- Advanced Solid Tumor, Epithelioid Sarcoma, FL Lymphoma, +15 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
- NEXT Oncology San Antonio, Texas, United States
NCT06829771
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- Maanshan People's Hospital Ma’anshan, Anhui, China
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
NCT06357676
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT07114367
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Chonnam National University Hwasun Hospital Hwasun, South Korea
- Seoul National University Bundang Hospital Seongnam, South Korea
- Catholic univ of Yeouido St Mary's Hospital Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
Recruiting
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
NCT06909877
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sichuan Cancer Hospital Chengdu, China
NCT04669171
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
- University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) Rochester, New York, United States
- University of Washington-Seattle Cancer Care Alliance Seattle, Washington, United States